Einde keuzehulp

U bent klaar met het invullen van de keuzehulp.

Bespreek de samenvatting met uw arts.
Samen kiest u de behandeling die het beste bij u past.

Uw samenvatting

U kunt de samenvatting bewaren.
Zo kunt u alles nog eens nalezen en bespreken met uw partner, familie of vrienden.
Kies 1 van de volgende manieren: 
 

Meer informatie over borst-reconstructie:

Meer informatie over samen beslissen:

Deze keuzehulp is gebaseerd op de richtlijn Borstreconstructie (versie 2019) van de Nederlandse Vereniging voor Plastische Chirurgie.
Ook zijn de volgende bronnen gebruikt:

  1. Bargon CA, Young-Afat DA, Ikinci M, et al. Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction—A systematic review and meta-analysis. Cancer. 2022;128(19):3449-3469. doi:10.1002/cncr.34393. Hier te vinden
  2. Saldanha IJ, Cao W, Broyles JM, et al. Breast reconstruction after mastectomy: a systematic review and meta-Analysis. 2021. doi:10.23970/AHRQEPCCER245. Hier te vinden
  3. Goncalves R, Mota BS, Sobreira-Lima B, et al. The oncological safety of autologous fat grafting: a systematic review and meta-analysis. BMC Cancer. 2022;22(1). doi:10.1186/s12885-022-09485-5. Hier te vinden
  4. Krastev TK, Schop SJ, Hommes J, Piatkowski AA, Heuts EM, van der Hulst RRWJ. Meta-analysis of the oncological safety of autologous fat transfer after breast cancer. British Journal of Surgery. 2018;105(9):1082-1097. doi:10.1002/bjs.10887. Hier te vinden
  5. Sousa H, Castro S, Abreu J, Pereira MG. A systematic review of factors affecting quality of life after postmastectomy breast reconstruction in women with breast cancer. Psychooncology. 2019;28(11):2107-2118. doi:10.1002/pon.5206. Hier te vinden
  6. Suárez SL, Eugenia M, Crespo O, María J, Sánchez B, Herrera De La Muela M. Psychological implications of risk-reducing mastectomies in BRCA1/2 mutation carriers. Cirurgía Espanola. 2021;100(1):7-17. doi:10.1016/j.cireng.2021.06.014. Hier te vinden
  7. Carr TL, Groot G, Cochran D, Holtslander L. Patient information needs and breast reconstruction after mastectomy: a qualitative meta-synthesis. Cancer Nurs. 2019;42(3):229-241. doi:10.1097/NCC.0000000000000599. Hier te vinden
  8. Varghese J, Gohari SS, Rizki H, et al. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction. Breast. 2021;55:55-62. doi:10.1016/j.breast.2020.11.023. Hier te vinden
  9. Vos E, Koppert L, van Lankeren W, Verhoef C, Koerkamp BG, Hunink M. A preliminary prediction model for potentially guiding patient choices between breast conserving surgery and mastectomy in early breast cancer patients; a Dutch experience. Quality of Life Research. 2018;27(2):545-553. doi:10.1007/s11136-017-1740-0. Hier te vinden
  10. Tyner TE, Lee MA. Satisfaction outcomes in women who “choose to go flat” after mastectomy: an integrative review. Advances in Nursing Science. 2021;44(1):31-51. doi:10.1097/ANS.0000000000000329. Hier te vinden
  11. Eltahir Y, Werners LLCH, Dreise MM, et al. Quality-of-life outcomes between mastectomy alone and breast reconstruction: Comparison of patient-reported BREAST-Q and other health-related quality-of-life measures. Plast Reconstr Surg. 2013;132:201e-209e. doi:10.1097/PRS.0b013e31829586a7. Hier te vinden
  12. Awadeen A, Fareed M, Elameen AM. The impact of postmastectomy radiation therapy on the outcomes of prepectoral implant-based breast reconstruction: a systematic review and meta-analysis. Aesthetic Plast Surg. Published online February 1, 2022. doi:10.1007/s00266-022-03026-y. Hier te vinden
  13. Kouwenberg CAE, De Ligt KM, Kranenburg LW, et al. Long-term health-related quality of life after four common surgical treatment options for breast cancer and the effect of complications: a retrospective patient-reported survey among 1871 patients. Plast Reconstr Surg 2020;146:1-13. doi:10.1097/PRS.0000000000006887. Hier te vinden
  14. Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: A systematic review. Plast Reconstr Surg. 2013;132(3):511-518. doi:10.1097/PRS.0b013e31829acc41. Hier te vinden
  15. Steffenssen MCW, Kristiansen ALH, Damsgaard TE. A systematic review and meta-analysis of functional shoulder impairment after latissimus dorsi breast reconstruction. Ann Plast Surg. 2019;82(1):116-127. doi:10.1097/SAP.0000000000001691. Hier te vinden
  16. Chirappapha P, Thaweepworadej P, Chitmetha K, et al. Comparisons of complications between extended latissimus dorsi flap and latissimus dorsi flap in total breast reconstruction: A prospective cohort study. Annals of Medicine and Surgery. 2020;56:197-202. doi:10.1016/j.amsu.2020.05.046. Hier te vinden
  17. Chung JH, Sohn SM, Jung SP, Park SH, Yoon ES. Effects of pre-existing abdominal scar on postoperative complications after autologous breast reconstruction using abdominal flaps: A systematic review and meta-analysis. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2021;74(2):277-289. doi:10.1016/j.bjps.2020.11.020. Hier te vinden
  18. Fu A, Liu C. Is pregnancy following a TRAM or DIEP flap safe? A critical systematic review and meta-analysis. Aesthetic Plast Surg. 2021;45(6):2618-2630. doi:10.1007/s00266-021-02289-1. Hier te vinden
  19. Nelson JA, Voineskos SH, Qi J, et al. Elective revisions after breast reconstruction: results from the Mastectomy Reconstruction Outcomes Consortium. Plast Reconstr Surg. 2019;144(6):1280-1290. doi:10.1097/PRS.0000000000006225. Hier te vinden
  20. Mortada H, Alnojaidi TF, Alrabah R, Almohammadi Y, Alkhashan R, Aljaaly H. Morbidity of the donor site and complication rates of breast reconstruction with autologous abdominal flaps: a systematic review and meta-analysis. Breast Journal. 2022;2022. doi:10.1155/2022/7857158. Hier te vinden
  21. Cao Z, Cao J, Pang X, Du W, Wu P. A comparative study for the rate of adverse outcomes in unilateral and bilateral abdominal flap breast reconstruction: a meta-analysis. Medicine. 2020;99(37):e22096. doi:10.1097/MD.0000000000022096. Hier te vinden
  22. Espinosa-De-Los-Monteros A, Frias-Frias R, Alvarez-Tostado-Rivera A, Caralampio-Castro A, Llanes S, Saldivar A. Postoperative abdominal bulge and hernia rates in patients undergoing abdominally based autologous breast reconstruction: systematic review and meta-analysis. Ann Plast Surg. 2021;86(4):476-484. doi:10.1097/SAP.0000000000002538. Hier te vinden
  23. Piatkowski AA, Wederfoort JLM, Hommes JE, et al. Effect of total breast reconstruction with autologous fat transfer using an expansion device vs implants on quality of life among patients with breast cancer: a randomized clinical trial. JAMA Surg. 2023;Mar 1:e227625. doi:10.1001/jamasurg.2022.7625. Hier te vinden
  24. Kempa S, Brix E, Heine N, et al. Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience. Arch Gynecol Obstet. 2022;305(4):921-927. doi:10.1007/s00404-021-06241-1. Hier te vinden
  25. Lemaitre J, Boiffard F, Dravet F, Renaudeau C, Guerin-Charbonnel C, Brillaud-Meflah V. Exclusive autologous fat grafting: feasibility, satisfaction, and quality of life. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2022;75(10):3707-3714. doi:10.1016/j.bjps.2022.06.055. Hier te vinden
  26. Fracol M, Allison S, Chu Y, et al. The palpable nodule after autologous fat grafting: distinguishing benign versus malignant lesions in breast reconstruction. Plast Reconstr Surg. 2022;150:20S-29S. doi:10.1097/PRS.0000000000009496. Hier te vinden
  27. Wederfoort JLM, Hebels SA, Heuts EM, van der Hulst RRWJ, Piatkowski AA. Donor site complications and satisfaction in autologous fat grafting for breast reconstruction: A systematic review. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2022;75(4):1316-1327. doi:10.1016/j.bjps.2022.01.029. Hier te vinden
  28. Wederfoort JLM, van Santbrink E, Hommes JE, et al. Donor site satisfaction following autologous fat transfer for total breast reconstruction. Aesthet Surg J. 2023;43(1):40-48. doi:10.1093/asj/sjac125. Hier te vinden

 

PatientPlus ontwikkelt keuzehulpen met veel zorg en aandacht. Iedere 2 jaar updaten we de keuzehulp.

Hierbij volgen wij de Internationale Kwaliteitsstandaard IPDAS, de ‘Leidraad keuzehulp bij richtlijnen’ en de meest recente wetenschappelijke literatuur.

In nauwe samenwerking met zorgverleners en patiënten stellen we de inhoud samen. We vragen de wetenschappelijke- en patiëntenorganisaties om betrokken te zijn bij de ontwikkeling en updates.

Geen van de betrokkenen heeft conflicterende belangen met betrekking tot deze keuzehulp. ICMJE Conflict of Interest Forms van alle auteurs zijn opgeslagen en beschikbaar op aanvraag.

Meer over de ontwikkeling en implementatie van onze keuzehulpen kunt u hier lezen.

Ontwikkeld door:

Gesteund door:

Versie: 20 maart 2023

Gefinancierd door: PatientPlus

Uw mening

Selecteer het aantal sterren en klik op 'verstuur'.


U kunt de keuzehulp afsluiten.


logo-P+CZ3

Contact: PatientPlus

Adres: Zeestraat 76, 2518 AD, Den Haag
Email: contact@patientplus.info
Website: www.patientplus.info
Telefoon: 085-0188738